Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, has been named for the sixth ...
Over the past year, the shadow of the Grail deal has hung over Illumina despite its reinvigorated leadership and launch of ...
La empresa local de secuenciación genética citó ahorros de costos para alinearse con su futura estrategia comercial.
Illumina's innovation pipeline remains a critical factor in its future success. The company recently announced the MiSeq i100 series, which analysts believe could significantly expand Illumina's ...
Illumina's innovation pipeline remains a critical factor in its future success. The company recently announced the MiSeq i100 series, which analysts believe could significantly expand Illumina's Total ...
The Genomics Core offers a wide range of genomic and DNA/RNA services. We operate the Illumina NovaSeq X Plus, NextSeq 550, and MiSeq platforms for all Next Generation Sequencing and offer an ...
The MiSeq desktop sequencer offers low throughput flowcells and long read lengths. It is best for small whole-genome sequencing, targeted gene sequencing, metagenomics, and CRISPR validation. The ...